Pyxis Oncology Correlations

PYXS Stock  USD 3.58  0.22  6.55%   
The current 90-days correlation between Pyxis Oncology and Invivyd is 0.02 (i.e., Significant diversification). The correlation of Pyxis Oncology is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Pyxis Oncology Correlation With Market

Good diversification

The correlation between Pyxis Oncology and DJI is -0.05 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Pyxis Oncology and DJI in the same portfolio, assuming nothing else is changed.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pyxis Oncology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in consumer price index.
For more information on how to buy Pyxis Stock please use our How to Invest in Pyxis Oncology guide.

Moving together with Pyxis Stock

  0.87QVCGA QVC Group Symbol ChangePairCorr
  0.63CHNXF ChitogenXPairCorr
  0.9AA Alcoa Corp Earnings Call TomorrowPairCorr
  0.64BAC Bank of America Aggressive PushPairCorr
  0.9INTC Intel Aggressive PushPairCorr
  0.62JPM JPMorgan ChasePairCorr
  0.67WMT Walmart Aggressive PushPairCorr
  0.87JNJ Johnson JohnsonPairCorr
  0.84GE GE Aerospace Earnings Call TodayPairCorr

Moving against Pyxis Stock

  0.77BKNG Booking HoldingsPairCorr
  0.61AMKBY AP Moeller MaerskPairCorr
  0.48GRYP GRYP Old Symbol ChangePairCorr
  0.44VLCN Volcon Inc Symbol ChangePairCorr
  0.74DIS Walt DisneyPairCorr
  0.67KO Coca Cola Earnings Call TodayPairCorr
  0.58VZ Verizon Communications Aggressive PushPairCorr
  0.53T ATT Inc Earnings Call TomorrowPairCorr
  0.53PG Procter Gamble Earnings Call This WeekPairCorr

Related Correlations Analysis


Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

TARASAVA
CRBPTARA
CRBPSAVA
CDXSOABI
CRBPIVVD
TARASGMO
  

High negative correlations

IMRXOABI
CDXSIMRX
OABIIVVD
CDXSIVVD
CRBPOABI
CRBPCDXS

Risk-Adjusted Indicators

There is a big difference between Pyxis Stock performing well and Pyxis Oncology Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Pyxis Oncology's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
IVVD  7.51  2.12  0.26  64.76  6.24 
 15.24 
 99.46 
SAVA  4.93  1.11  0.29  0.49  3.75 
 10.10 
 57.72 
SGMO  3.86  0.39  0.10  0.23  3.60 
 9.09 
 27.64 
OABI  2.71 (0.29) 0.00 (0.05) 0.00 
 5.59 
 17.86 
IMRX  5.69  0.80  0.11 (3.68) 6.11 
 18.49 
 51.45 
OBIO  3.40  0.32  0.08  0.21  4.72 
 9.84 
 25.17 
TARA  3.31  0.91  0.34  0.86  2.24 
 11.04 
 24.49 
CDXS  2.68 (0.15)(0.02) 0.00  3.55 
 6.64 
 17.24 
CRBP  3.06  1.25  0.34 (35.88) 2.40 
 9.61 
 22.13 
GNFT  2.73  0.10  0.05  0.12  3.08 
 7.67 
 25.31 

Pyxis Oncology Corporate Management

Thuy PharmDVP PharmacologyProfile
Donna RegaladoHead ResourcesProfile
Jan PinkasChief OfficerProfile
Pamela MBAChief OfficerProfile
Marsha CrochiereHead ResearchProfile
Sondra SmyrniosHead OperationsProfile
Charles GombarSenior ManagementProfile